The Client
One of the UK's largest healthcare organisations, with around 14,000 staff and annual turnover of approximately £1.2 billion. A provider of acute, specialist, and community services, and a cornerstone of regional healthcare delivery and innovation. Nationally recognised for clinical excellence. Institutionally, carrying the weight of four decades of leadership under a single, defining chief executive.
The Challenge
Forty years of leadership under one person does not just create a succession challenge, it creates an identity challenge. The culture, the relationships, the informal decision-making architecture of a complex healthcare organisation all take the shape of the leadership that built them. So when that leadership changes, and especially when it changes at both the chair and chief executive level simultaneously, the organisation isn't simply filling two roles. It's facing a moment that will shape what it becomes next.
The board was clear about one thing: they did not want a replica. They wanted leaders who would bring fresh perspective, renewed energy, and the kind of behavioural authenticity that signals real change rather than managed continuity. At the same time, they needed the organisation to remain stable through the transition. This is the tension at the heart of almost every major succession: continuity vs renewal, and only rarely do organisations manage both.
The timing, which nobody could have known at the time, made the quality of this process matter even more. The organisation would become one of the first in the UK to treat COVID-19 patients. The leadership team appointed through this process would be responding to a national health emergency within months of taking up their roles.
What We Did
Wharton Global began not with candidates but with the organisation. A forensic diagnostic of the current state, the cultural opportunity, and the leadership demands of the next chapter came before any profile of the ideal candidate was written.
This included a structured review of staff survey data, covering culture, leadership effectiveness, and engagement trends. It included performance and quality metrics interpreted through a leadership lens: what were the patterns, and what did they suggest about where leadership had been strong and where it had been absent? It also included a careful analysis of cultural indicators, specifically how recognition patterns mapped to the organisation's stated values, which is one of the most reliable early signals of whether a culture is genuinely values-led or merely values-aware.
In-depth strategic briefing sessions with the board then defined the leadership behaviours required for the next period. Not competency framework language, but specific, behavioural descriptions of what the organisation needed to look different in practice. Collaborative decision-making. Visible openness to challenge. Resilience under scrutiny. The board knew what it was describing, because it had watched the alternative for four decades and knew what it wanted to change.
The scope of the brief then expanded from the chief executive to include the chair and the wider executive team. This was deliberate. Chair and chief executive were appointed in tandem, with the explicit understanding that their partnership in setting organisational tone was as important as the capability of each individual. A board that appoints a transformational chief executive and a conservative chair, or vice versa, has created a governance fault line before either person has walked in the door.
Every candidate was assessed using structured psychometric profiling to evaluate agility, values alignment, and potential derailers under pressure. Behavioural risk analysis was used to anticipate how each candidate was likely to perform under the kind of complexity and crisis that a major healthcare organisation will inevitably face. In-depth interviews explored track record, cultural impact, and alignment with the board's renewed direction. The same framework was subsequently applied to the Chief Operating Officer and senior nursing leadership appointments. From the outset, consistency across the top team was a matter of governance, not something left to evolve.
The Results
The leadership transition was completed. Months later, the COVID-19 pandemic arrived.
The organisation became one of the first in the UK to treat COVID patients. The new executive team, in post for only a matter of months, responded with the clarity, cohesion, and collective resilience that a crisis of that scale demanded. The decisions were made quickly. Communication was consistent. The team did not fracture under pressure.
That performance was not coincidental. It was the consequence of a selection process that had treated resilience under uncertainty as a core criterion, that had appointed leaders whose values were compatible under pressure rather than just complementary under normal conditions, and that had built a top team designed to function together rather than alongside each other.
Over five years of partnership following the initial appointments, the engagement extended across all senior board and executive appointments, executive coaching to embed cultural change, and ongoing behavioural and values alignment across the leadership group. Engagement scores improved. Cultural recognition strengthened. Confidence in leadership, from staff, from the board, and from the wider system, measurably increased across the period.
